Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q2

9627.TEDINET S100SH2U
Period2023-05-01 → 2023-10-31
Filed2023-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥193.7bn2023-05-01 → 2023-10-31Cons.Net sales
Revenue¥358.7bn2022-05-01 → 2023-04-30Cons.Net sales (5-year summary)
Revenue¥171.2bn2022-05-01 → 2022-10-31Cons.Net sales
Operating income¥8.7bn2023-05-01 → 2023-10-31Cons.Operating income
Operating income¥6.8bn2022-05-01 → 2022-10-31Cons.Operating income
Ordinary income¥9.3bn2023-05-01 → 2023-10-31Cons.Ordinary income
Ordinary income¥17.1bn2022-05-01 → 2023-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.3bn2022-05-01 → 2022-10-31Cons.Ordinary income
Profit before tax¥9.4bn2023-05-01 → 2023-10-31Cons.Income before income taxes
Profit before tax¥7.2bn2022-05-01 → 2022-10-31Cons.Income before income taxes
Net income (owners)¥5.3bn2023-05-01 → 2023-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.2bn2022-05-01 → 2023-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss attributable to owners of parent
Net income¥5.2bn2023-05-01 → 2023-10-31Cons.Profit loss
Net income¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss
Total assets¥242.9bnat 2023-10-31Cons.Assets
Total assets¥231.8bnat 2023-04-30Cons.Assets
Total assets¥231.3bnat 2022-10-31Cons.Total assets (5-year summary)
Total liabilities¥113.1bnat 2023-10-31Cons.Liabilities
Total liabilities¥105.2bnat 2023-04-30Cons.Liabilities
Net assets / equity¥129.8bnat 2023-10-31Cons.Net assets
Net assets / equity¥126.5bnat 2023-04-30Cons.Net assets
Net assets / equity¥120.9bnat 2022-10-31Cons.Net assets (5-year summary)
Cash and deposits¥50.5bnat 2023-10-31Cons.Cash and deposits
Cash and deposits¥46.8bnat 2023-04-30Cons.Cash and deposits
Cash & equivalents¥50.3bnat 2023-10-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2023-04-30Cons.Cash and cash equivalents
Cash & equivalents¥43.5bnat 2022-10-31Cons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30dCons.Cash and cash equivalents
Operating cash flow¥14.1bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥20.3bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥8.5bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥5.8bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥22.3bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18.6bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.2bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥11.2bn2022-05-01 → 2023-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.8bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥149.662023-05-01 → 2023-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.732023-08-01 → 2023-10-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥262.872022-05-01 → 2023-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.322022-05-01 → 2022-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.782022-08-01 → 2022-10-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.4%at 2023-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.6%at 2023-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio52.2%at 2022-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue external2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue intersegment2023-05-01 → 2023-10-31¥24m
Otherother segmentssegment ordinary income2023-05-01 → 2023-10-31−¥49m
Reconciling Itemsreconcilingrevenue2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2023-10-31−¥4.4bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥12.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥1.3bn
—segment totalrevenue2023-05-01 → 2023-10-31¥193.8bn
—segment totalrevenue external2023-05-01 → 2023-10-31¥193.7bn
—segment totalrevenue intersegment2023-05-01 → 2023-10-31¥24m
—segment totalsegment ordinary income2023-05-01 → 2023-10-31¥13.8bn
Otherother segmentsrevenue2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue external2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-10-31¥31m
Otherother segmentssegment ordinary income2022-05-01 → 2022-10-31−¥18m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-10-31−¥3.8bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥10.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥349m
—segment totalrevenue2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue external2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue intersegment2022-05-01 → 2022-10-31¥31m
—segment totalsegment ordinary income2022-05-01 → 2022-10-31¥11.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 555
ItemContextValueUnit
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration586000000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYTDDuration564000000JPY
Decrease increase in other investments inv cfPrior1YTDDuration-123000000JPY
Decrease increase in other investments inv cfCurrentYTDDuration-883000000JPY
Proceeds from withdrawal of time deposits inv cfPrior1YTDDuration362000000JPY
Proceeds from withdrawal of time deposits inv cfCurrentYTDDuration402000000JPY
Payments into time deposits inv cfPrior1YTDDuration-206000000JPY
Payments into time deposits inv cfCurrentYTDDuration-6000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-18617000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-5793000000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration-123000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration－JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration10000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration－JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-3492000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-2121000000JPY
Redemption of bonds fin cfPrior1YTDDuration-240000000JPY
Redemption of bonds fin cfCurrentYTDDuration－JPY
Repayments of lease obligations fin cfPrior1YTDDuration-16000000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-8000000JPY
Cash dividends paid fin cfPrior1YTDDuration-1932000000JPY
Cash dividends paid fin cfCurrentYTDDuration-2107000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-5793000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-4237000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-15955000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration4063000000JPY
Cash and cash equivalentsPrior2YearInstant59470000000JPY
Cash and cash equivalentsPrior1YearInstant46217000000JPY
Cash and cash equivalentsPrior1QuarterInstant43514000000JPY
Cash and cash equivalentsCurrentQuarterInstant50280000000JPY
Advertising expenses sgaPrior1YTDDuration1064000000JPY
Advertising expenses sgaCurrentYTDDuration1049000000JPY
Directors compensations sgaPrior1YTDDuration265000000JPY
Directors compensations sgaCurrentYTDDuration228000000JPY
Salaries allowances and bonuses sgaPrior1YTDDuration4000000000JPY
Salaries allowances and bonuses sgaCurrentYTDDuration4010000000JPY
Legal and employee benefits expenses sgaPrior1YTDDuration1370000000JPY
Legal and employee benefits expenses sgaCurrentYTDDuration1465000000JPY
Correspondence and transportation expenses sgaPrior1YTDDuration607000000JPY
Correspondence and transportation expenses sgaCurrentYTDDuration689000000JPY
Rents sgaPrior1YTDDuration2714000000JPY
Rents sgaCurrentYTDDuration2632000000JPY
Depreciation sgaPrior1YTDDuration717000000JPY
Depreciation sgaCurrentYTDDuration808000000JPY
Amortization of goodwill sgaPrior1YTDDuration2072000000JPY
Amortization of goodwill sgaCurrentYTDDuration2156000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember153248000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember12205000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember5750000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember171204000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-04-30pass
balance sheet identityconsolidated 2023-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-04-30pass
statement vs summary · net assetsconsolidated 2023-10-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-10-31pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2023-10-31pass
statement vs summary · operating cash flowconsolidated 2022-05-01/2022-10-31pass
statement vs summary · operating cash flowconsolidated 2023-05-01/2023-10-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-10-31pass
statement vs summary · revenueconsolidated 2023-05-01/2023-10-31pass
statement vs summary · total assetsconsolidated 2023-04-30pass
statement vs summary · total assetsconsolidated 2023-10-31pass